{"id":1398,"date":"2025-04-02T15:32:00","date_gmt":"2025-04-02T20:32:00","guid":{"rendered":"https:\/\/www.rqmplus.com\/?p=1398"},"modified":"2025-06-19T10:56:10","modified_gmt":"2025-06-19T15:56:10","slug":"braving-the-tariff-storm-strategies-for-medtech-companies","status":"publish","type":"post","link":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","title":{"rendered":"Braving the Tariff Storm: Strategies for MedTech Companies"},"content":{"rendered":"\n<p>The U.S. administration has announced plans to implement a 25% tariff on imported medical technologies (MedTech), pharmaceuticals, and automobiles, set to take effect <strong>today, April 2, 2025.<\/strong> This significant policy shift will undoubtedly impact the MedTech industry, requiring companies to <a href=\"https:\/\/www.rqmplus.com\/solutions\/regulatory-quality\/\">adapt their strategies<\/a> to mitigate the financial burden. Considering recent political instability, it&#8217;s crucial to reassess and optimize your supply chain and manufacturing processes.<\/p>\n\n\n\n<p>At RQM+, we understand the complexities and challenges that come with such regulatory changes. With a collective <strong>50 years of direct FDA experience<\/strong> and<strong> 20 years combined notified body experience<\/strong>, our team is here to provide regulatory guidance and strategic advisory to help you navigate this tariff storm effectively.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Protect Your Margins<\/h2>\n\n\n\n<p>In response to the increased tariffs, RQM+ offers optimized <a href=\"https:\/\/www.rqmplus.com\/solutions\/\">regulatory and supply chain strategies<\/a> to protect your margins. <strong>Here are three potential actions you might consider:<\/strong><\/p>\n\n\n\n<ol style=\"margin-top:0px\" class=\"wp-block-list\">\n<li><strong>Bring Manufacturing into the U.S<\/strong><strong>.<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Transfer Process<\/strong>: Moving manufacturing from overseas locations to the U.S. can be a significant process unless a duplicate process is already in place at a U.S. facility. If a qualified line exists in the U.S. and we are looking to expand the line, there may be an opportunity to move faster, but savings might be limited or the increased costs even higher than the tariffs.<br><\/li>\n\n\n\n<li><strong>New Manufacturing Capability<\/strong>: Setting up a new manufacturing capability with full setup and qualification of a new line is a longer-term strategy and may take 1-2 years. In addition to the infrastructure costs, the increased production cost may offset any benefit of avoiding the tariff in the short-term, which would require additional due diligence to justify the cost of the move.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Optimize Supply Chain for Non-U.S. Distribution<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Final Packaging and Release<\/strong>: If products are manufactured in a low-cost country (LCC) and shipped to a U.S. site for final packaging and release, it may be practical to set up the site for product release and ship directly to non-U.S. distribution points without entering the U.S. and being subject to potential tariffs.<br><\/li>\n\n\n\n<li><strong>Certification Process<\/strong>: If the site is set up as a manufacturer, qualifying a release process may be accomplished in 3-6 months. If the non-U.S. manufacturing site is not registered and certified as a medical device manufacturer, the certification process can be extensive and costly (6-18 months), factors that need to be evaluated if considering a longer-term strategy.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Local Supplier Selection and Qualification<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Local Production Benefits<\/strong>: Selecting and qualifying local suppliers to manufacture parts for assembly in a U.S. production facility may bring additional benefits, such as tighter control of the supplier and shorter, more stable supply chains. A local supply chain may reduce the time needed to implement future changes to a few months, compared to those typical with LCC supply chains of 6-12 months, allowing for reduced scrap costs and improved supplier controls throughout the change process.<br><\/li>\n\n\n\n<li><strong>Rapid Implementation<\/strong>: For smaller companies with limited in-house manufacturing capacity, moving from a supplier in China or another LCC to one nearby may bring advantages that allow for faster responsiveness to customer needs that offset some of the cost considerations<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">Leveraging RQM+ FDA Experience<\/h2>\n\n\n\n<p>Given the uncertainty, MedTech companies need trusted partners with deep regulatory expertise to help them navigate evolving approval processes. RQM+ has former FDA experts who have worked inside the agency and understand how regulatory decisions are made. Our team of ex-FDA professionals helps anticipate potential roadblocks and ensures regulatory strategies are aligned with evolving expectations.<\/p>\n\n\n\n<p><strong>Looking for additional insights from RQM+ subject matter experts?<\/strong> Check out a recent LinkedIn article by VP, Global Regulatory Affairs, Dr. Jaishankar Kutty, <a href=\"https:\/\/www.linkedin.com\/pulse\/medtech-tariffs-strategic-guide-industry-under-siege-kutty-ph-d--3d8sc\"><em>MedTech Tariffs: A Strategic Guide for an Industry Under Siege.<\/em><\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contact Us<\/h2>\n\n\n\n<p>Need help navigating these new tariffs?&nbsp;<a href=\"\/about\/contact\">Contact us<\/a>&nbsp;today. Our friendly team at RQM+ is ready to assist you in addressing market uncertainty and ensuring your MedTech products remain competitive. <a href=\"\/book-consultation\">We&#8217;re here to make your MedTech happen!<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. administration has announced plans to implement a 25% tariff on imported medical technologies (MedTech), pharmaceuticals, and automobiles, set&#8230;<\/p>\n","protected":false},"author":3,"featured_media":1415,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[12,15],"tags":[],"resource-type":[28],"topic":[9,11],"region":[],"class_list":["post-1398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulatory-quality","category-reimbursement","resource-type-blog","topic-regulatory-quality","topic-reimbursement"],"acf":[],"card_info":{"title":"Braving the Tariff Storm: Strategies for MedTech Companies","link":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","link_target":"_self","name":"Blog","slug":"blog","thumbnail":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","excerpt":"The U.S. administration has announced plans to implement a 25% tariff on imported medical technologies (MedTech), pharmaceuticals, and automobiles, set...","display_date":"April 2, 2025"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+<\/title>\n<meta name=\"description\" content=\"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+\" \/>\n<meta property=\"og:description\" content=\"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"RQM+\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RQMplus\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T20:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-19T15:56:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1438\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marc Wagner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:site\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marc Wagner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\"},\"author\":{\"name\":\"Marc Wagner\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/4d42649879ce628f5f97a730b9e3342d\"},\"headline\":\"Braving the Tariff Storm: Strategies for MedTech Companies\",\"datePublished\":\"2025-04-02T20:32:00+00:00\",\"dateModified\":\"2025-06-19T15:56:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\"},\"wordCount\":659,\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg\",\"articleSection\":[\"Regulatory &amp; Quality\",\"Reimbursement\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\",\"url\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\",\"name\":\"MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg\",\"datePublished\":\"2025-04-02T20:32:00+00:00\",\"dateModified\":\"2025-06-19T15:56:10+00:00\",\"description\":\"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg\",\"width\":2560,\"height\":1438,\"caption\":\"Top view of colorful shipping containers at a bustling port in Jakarta, Indonesia.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rqmplus.com\/#website\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"name\":\"RQM+\",\"description\":\"Evolving MedTech\",\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rqmplus.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rqmplus.com\/#organization\",\"name\":\"RQM+\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"width\":696,\"height\":696,\"caption\":\"RQM+\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/RQMplus\",\"https:\/\/x.com\/RQMplus\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/4d42649879ce628f5f97a730b9e3342d\",\"name\":\"Marc Wagner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b4a6835831f2de0b0b1fce0bb4a66a73d766678c0b5ea4be80c0d4cdaf336d6f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b4a6835831f2de0b0b1fce0bb4a66a73d766678c0b5ea4be80c0d4cdaf336d6f?s=96&d=mm&r=g\",\"caption\":\"Marc Wagner\"},\"url\":\"https:\/\/www.rqmplus.com\/blog\/author\/marcwscorrmarketing-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+","description":"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","og_locale":"en_US","og_type":"article","og_title":"MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+","og_description":"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.","og_url":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","og_site_name":"RQM+","article_publisher":"https:\/\/www.facebook.com\/RQMplus","article_published_time":"2025-04-02T20:32:00+00:00","article_modified_time":"2025-06-19T15:56:10+00:00","og_image":[{"width":2560,"height":1438,"url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","type":"image\/jpeg"}],"author":"Marc Wagner","twitter_card":"summary_large_image","twitter_creator":"@RQMplus","twitter_site":"@RQMplus","twitter_misc":{"Written by":"Marc Wagner","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#article","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/"},"author":{"name":"Marc Wagner","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/4d42649879ce628f5f97a730b9e3342d"},"headline":"Braving the Tariff Storm: Strategies for MedTech Companies","datePublished":"2025-04-02T20:32:00+00:00","dateModified":"2025-06-19T15:56:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/"},"wordCount":659,"publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"image":{"@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","articleSection":["Regulatory &amp; Quality","Reimbursement"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","url":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/","name":"MedTech Tariffs: Strategic Responses to New Import Challenges | RQM+","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage"},"image":{"@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","datePublished":"2025-04-02T20:32:00+00:00","dateModified":"2025-06-19T15:56:10+00:00","description":"Understand the implications of new U.S. tariffs on medical technologies and explore strategic options for MedTech companies to mitigate financial impacts.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/blog\/braving-the-tariff-storm-strategies-for-medtech-companies\/#primaryimage","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/05\/top-view-of-colorful-shipping-containers-at-a-bustling-port-in-jakarta-indonesia.-1427107-scaled.jpg","width":2560,"height":1438,"caption":"Top view of colorful shipping containers at a bustling port in Jakarta, Indonesia."},{"@type":"WebSite","@id":"https:\/\/www.rqmplus.com\/#website","url":"https:\/\/www.rqmplus.com\/","name":"RQM+","description":"Evolving MedTech","publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rqmplus.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rqmplus.com\/#organization","name":"RQM+","url":"https:\/\/www.rqmplus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","width":696,"height":696,"caption":"RQM+"},"image":{"@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RQMplus","https:\/\/x.com\/RQMplus"]},{"@type":"Person","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/4d42649879ce628f5f97a730b9e3342d","name":"Marc Wagner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b4a6835831f2de0b0b1fce0bb4a66a73d766678c0b5ea4be80c0d4cdaf336d6f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4a6835831f2de0b0b1fce0bb4a66a73d766678c0b5ea4be80c0d4cdaf336d6f?s=96&d=mm&r=g","caption":"Marc Wagner"},"url":"https:\/\/www.rqmplus.com\/blog\/author\/marcwscorrmarketing-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts\/1398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/comments?post=1398"}],"version-history":[{"count":0,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/posts\/1398\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media\/1415"}],"wp:attachment":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media?parent=1398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/categories?post=1398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/tags?post=1398"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/resource-type?post=1398"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/topic?post=1398"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/region?post=1398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}